<DOC>
	<DOCNO>NCT01333709</DOCNO>
	<brief_summary>The purpose study determine whether tailored management locally advance rectal carcinoma improve oncologic functional outcome .</brief_summary>
	<brief_title>Multicenter Phase 2 Trial : Tailored Strategy Locally Advanced Rectal Carcinoma</brief_title>
	<detailed_description>Locally advanced rectal carcinoma raise issue oncological control , local general , therapeutic morbidity . Surgery alone cure one two patient , radiochemotherapy improve local control metastatic risk remain 30 % enhance postoperative morbidity poor functional result . The tumor response preoperative treatment major prognostic factor reveal aggressiveness tumor . To day , biologic predictive marker tumor response . The purpose trial tailor management accord early tumoral response short intensive induction trichemotherapy . MRI volumetric tumor response use distinguish good responder bad responder . `` Very good '' responder randomize either immediate surgery radiochemotherapy follow surgery ( Standard arm : Cap 50 ) . `` Good bad '' responder randomize two arm : intensive radiochemotherapy ( Cap 60 ) standard arm ( Cap 50 ) . This tailored management result well oncologic prognosis lower rate post therapeutic functional disorder .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histologically confirm rectal carcinoma Primary tumor evaluate pelvic MR Imaging : ) iT3 ≥c tumor , MRI show predictive CRM ≤ 2 mm EMS ( Extra Mural Spread ) ≥ 5 mm ii ) Resectable iT4 tumor ( randomize within `` poor responder '' group ) iii ) Any T tumor MRI show predictive CRM ≤ 1 mm No detectable metastasis : Thoraxabdomenpelvic CTscan Patient ≥ 18 year ECOG Performance Status 012 Patient information write informed consent form sign Patient receive radiotherapy chemotherapy Negative pregnancy test woman childbearing potential Patient cover Social Security system Hematology : Haemoglobin ≥ 9 g/dL , WBC ≥ 4000/mm3 , neutrophil ≥ 1.5 x 109/L , platelet ≥ 100 x 109/L Hepatic function : total bilirubin ≤ 1.5 x ULN , AST ALT ≤ 3 x ULN , Alkaline phosphatases ≤ 3 x ULN Renal function : creatinine ≤ 1.25 x ULN creatinine clearance ≥ 60 ml/min Indication immediate surgery Primary tumor measure MRI inclusion Previous pelvic radiotherapy Contraindication radiotherapy and/or chemotherapy Severe renal liver impairment Cardiac and/or coronary disease could contraindicate 5Fu administration Active infectious disease Peripheral sensitive neuropathy History prior cancer ( except cure 5 year ago , complete remission ) Patient ( male female ) reproductive potential use effective contraceptive method whole treatment 6 month completion treatment Concurrent participation clinical trial likely interfere therapeutic schedule Fertile female patient use adequate contraception , breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>locally advanced rectal carcinoma</keyword>
	<keyword>Tailored treatment strategy</keyword>
	<keyword>MRI volumetry</keyword>
	<keyword>Early tumor response</keyword>
</DOC>